J&J Manufacturing Woes Lead To Recall Of Children's Tylenol In Korea
This article was originally published in PharmAsia News
Johnson & Johnson's Janssen subsidiary ordered a recall of all 1.7 million bottles of its Children's Tylenol syrup produced and sold in South Korea, citing excessive levels of acetaminophen, which could cause liver damage.
You may also be interested in...
The HMA-EMA Big Data Task Force has offered recommendations to use data for the benefit of public health.